Cargando…
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
Autores principales: | Karkada, Mohan, Ogura, Mieko, Tovar, Vivian, Mitsuhashi, Masato, Berinstein, Neil, Mansour, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991261/ http://dx.doi.org/10.1186/2051-1426-1-S1-P106 |
Ejemplares similares
-
Plasma biomarker analysis of ovarian cancer patients undergoing immunotherapy with therapeutic cancer vaccine DPX-Survivac
por: Karkada, Mohan, et al.
Publicado: (2015) -
Therapeutic vaccines and cancer: focus on DPX-0907
por: Karkada, Mohan, et al.
Publicado: (2014) -
Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models
por: Weir, Genevieve, et al.
Publicado: (2014) -
Generation and utilization of polyfunctional anti-tumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2015) -
Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)